{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:01:56Z","timestamp":1792123316371,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["11013_33_2021-GIA HR"],"award-info":[{"award-number":["11013_33_2021-GIA HR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009589","name":"Jadavpur University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bioorg.2024.108057","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T11:25:47Z","timestamp":1734002747000},"page":"108057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Derivatives of D(\u2212)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis"],"prefix":"10.1016","volume":"154","author":[{"given":"Sanjib","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambati","family":"Himaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Regula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit Kumar","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insaf Ahmed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shovanlal","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-2439","authenticated-orcid":false,"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-738X","authenticated-orcid":false,"given":"Tarun","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.108057_b0005","unstructured":"R.E. Eden, J.M. Coviello, Chronic myelogenous leukemia [Updated 2023 Jan 16], In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531459\/ (accessed 30 September 2024)."},{"issue":"2024","key":"10.1016\/j.bioorg.2024.108057_b0010","first-page":"2191","article-title":"update on diagnosis, therapy, and monitoring","volume":"99","author":"Jabbour","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"2024","key":"10.1016\/j.bioorg.2024.108057_b0015","first-page":"12","article-title":"CA Cancer","volume":"74","author":"Siegel","year":"2024","journal-title":"J. Clin."},{"key":"10.1016\/j.bioorg.2024.108057_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1172910","article-title":"Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China","volume":"13","author":"Cheng","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.bioorg.2024.108057_b0025","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.3390\/cancers13194820","article-title":"Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance","volume":"13","author":"Alves","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2024.108057_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12951-024-02505-5","article-title":"Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN","volume":"22","author":"Sun","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.bioorg.2024.108057_b0035","unstructured":"A.A. Binzaid, O.J. Baqal, M. Soheib, M. Al Nahedh, H.H. Samarkandi, M. Aljurf, Cardiovascular toxicity associated with tyrosine kinase inhibitor therapy in chronic myeloid leukemia, Gulf J. Oncolog. 1(2021) 79-84."},{"key":"10.1016\/j.bioorg.2024.108057_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-1-15","article-title":"P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia","volume":"1","author":"Cang","year":"2008","journal-title":"J Hematol Oncol."},{"key":"10.1016\/j.bioorg.2024.108057_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41408-023-00823-9","article-title":"Management of chronic myeloid leukemia in 2023 - common ground and common sense","volume":"13","author":"Senapati","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bioorg.2024.108057_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113623","article-title":"Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies","volume":"223","author":"Das","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0055","doi-asserted-by":"crossref","unstructured":"M. Chang. Matrix metalloproteinase profiling and their roles in disease. RSC Adv. 13 (2023) 6304-6316. https:\/\/doi.org\/ 10.1039\/d2ra07005g.","DOI":"10.1039\/D2RA07005G"},{"key":"10.1016\/j.bioorg.2024.108057_b0060","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3389\/fimmu.2019.01278","article-title":"mechanisms of action of novel drugs targeting angiogenesis-promoting matrix metalloproteinases","volume":"10","author":"Fields","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2024.108057_b0065","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.108057_b0070","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2024.108057_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejmech.2017.09.052","article-title":"A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line","volume":"141","author":"Mukherjee","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116563","article-title":"Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis","volume":"274","author":"Das","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22255","article-title":"Biphenylsulfonamides as effective MMP-2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis","volume":"85","author":"Baidya","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0090","doi-asserted-by":"crossref","first-page":"e8672","DOI":"10.1002\/ccr3.8672","article-title":"Leukemia cutis revealing relapse of a chronic myeloid leukemia: A case report","volume":"12","author":"Ch\u00e9rif","year":"2024","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.bioorg.2024.108057_b0095","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.leukres.2007.01.015","article-title":"Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement","volume":"31","author":"Suminoe","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MPH.0000000000001386","article-title":"Expression and activity of matrix metalloproteinases in leukemia","volume":"41","author":"Amin Asnafi","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2024.108057_b0105","first-page":"1115","article-title":"Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes","volume":"5","author":"Ries","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0110","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.biocel.2012.08.021","article-title":"CIL-102 induces matrix metalloproteinase-2 (MMP-2)\/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability","volume":"44","author":"Liu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.108057_b0115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood-2006-02-005363","article-title":"Cell-surface association between matrix metalloproteinases and integrins: Role of the complexes in leukocyte migration and cancer progression","volume":"108","author":"Stefanidakis","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2024.108057_b0120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/10428190290026358","article-title":"Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea","volume":"43","author":"Bruchova","year":"2002","journal-title":"Leuk. Lymphoma."},{"key":"10.1016\/j.bioorg.2024.108057_b0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1365-2141.2002.03510.x","article-title":"Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: Potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia","volume":"117","author":"Lin","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bioorg.2024.108057_b0130","first-page":"681","article-title":"Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray","volume":"23","author":"Kaneta","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2024.108057_b0135","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4161\/cc.7.8.5645","article-title":"Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features","volume":"7","author":"Paupert","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2024.108057_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004320050161","article-title":"Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion","volume":"124","author":"Sawicki","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2024.108057_b0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jcp.24481","article-title":"Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)\/MMP-9 expression in human leukemia cells","volume":"229","author":"Liu","year":"2014","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.bioorg.2024.108057_b0150","first-page":"1679","article-title":"Synthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acids, Future","volume":"11","author":"Dutta","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0155","first-page":"17","article-title":"Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids: part II, Future","volume":"14","author":"Datta","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131512","article-title":"Synthesis, biological activity, structure activity relationship study and liposomal formulation development of some arylsulfonyl pyroglutamic acid derivatives","volume":"1248","author":"Das","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.108057_b0165","doi-asserted-by":"crossref","first-page":"17149","DOI":"10.1039\/D1NJ02636D","article-title":"Quantitative activity\u2013activity relationship (QAAR) driven design to develop hydroxamate derivatives of pentanoic acids as selective HDAC8 inhibitors: Synthesis, biological evaluation and binding mode of interaction studies","volume":"45","author":"Amin","year":"2021","journal-title":"New. J. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/1062936X.2021.1955414","volume":"32","author":"Das","year":"2021","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/1062936X.2022.2041722","article-title":"Insight into the structural requirements of gelatinases (MMP-2 and MMP-9) inhibitors by multiple validated molecular modelling approaches: Part II","volume":"33","author":"Das","year":"2022","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0180","doi-asserted-by":"crossref","unstructured":"S. Das, S. Gayen, T. Jha, In-house glutamine based compound loaded poly-(D-L-lactide-coglycolide) nanoparticles as a possible candidate for the management of chronic myeloid leukemia, Mater. Today Proc. 2023 (In press). https:\/\/doi.org\/10.1016\/j.matpr.2023.10.158.","DOI":"10.1016\/j.matpr.2023.10.158"},{"key":"10.1016\/j.bioorg.2024.108057_b0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12659\/MSMBR.893327","article-title":"Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0190","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1021\/acs.organomet.2c00290","article-title":"Impact of biphenyl benzhydrazone-incorporated arene Ru (II) complexes on cytotoxicity and the cancer cell death mechanism","volume":"41","author":"Arunachalam","year":"2022","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2024.108057_b0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jmi.12133","article-title":"Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques","volume":"255","author":"Atale","year":"2014","journal-title":"J. Microsc."},{"key":"10.1016\/j.bioorg.2024.108057_b0200","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","article-title":"Programmed cell death detection methods: A systematic review and a categorical comparison","volume":"27","author":"Kari","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2024.108057_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087223","article-title":"Molecular mechanisms of exopolysaccharide from Aphanothece halaphytica (EPSAH) induced apoptosis in HeLa cells","volume":"9","author":"Ou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.108057_b0210","article-title":"Antigenotoxic and apoptotic activity of green tea polyphenol extracts on hexavalent chromium-induced DNA damage in peripheral blood of CD-1 mice: Analysis with differential acridine orange\/ethidium bromide staining","volume":"2013","author":"Garc\u00eda-Rodr\u00edguez Mdel","year":"2013","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bioorg.2024.108057_b0215","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/IJN.S231062","article-title":"Synthesis, characterization, biomedical application, molecular dynamic simulation and molecular docking of schiff base complex of Cu(II) supported on Fe3O4\/SiO2\/APTS","volume":"15","author":"Eshaghi Malekshah","year":"2020","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.bioorg.2024.108057_b0220","doi-asserted-by":"crossref","first-page":"11568","DOI":"10.1038\/s41598-020-67289-8","article-title":"Angiogenesis Analyzer for ImageJ - A comparative morphometric analysis of \u201cEndothelial Tube Formation Assay\u201d and \u201cFibrin Bead Assay\u201d","volume":"10","author":"Carpentier","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.108057_b0225","series-title":"Schrodinger","author":"Suite","year":"2019"},{"key":"10.1016\/j.bioorg.2024.108057_b0230","doi-asserted-by":"crossref","first-page":"12033","DOI":"10.1021\/acs.jmedchem.3c00614","article-title":"Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer","volume":"66","author":"Pulya","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114470","article-title":"Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer","volume":"238","author":"Pulya","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105446","article-title":"Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model","volume":"117","author":"Routholla","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.108057_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111962","article-title":"Facile green synthesis of non-genotoxic, non-hemolytic organometallic silver nanoparticles using extract of crushed, wasted, and spent Humulus lupulus (hops): Characterization, anti-bacterial, and anti-cancer studies","volume":"204","author":"Das","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.bioorg.2024.108057_b0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2567.2007.02728.x","article-title":"Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages","volume":"124","author":"Oviedo-Orta","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.bioorg.2024.108057_b0255","unstructured":"RCSB protein Data Bank. https:\/\/www.rcsb.org\/, 2022. (Accessed 31 August 2024)."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824009623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:58:58Z","timestamp":1777463938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824009623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0045206824009623"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108057","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derivatives of D(\u2212)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.108057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108057"}}